Pancreatic Cancer Research at TGen Gets $18 Million Infusion

How bad is pancreatic cancer? Ninety percent of people who find out they have it die within a year. And the pancreas isn't even a brand-name digestive organ, like the kidney or liver. The ghastly statistic is one reason the gene-science gurus at TGen in Phoenix are major recipients in $74 million of gifts being distributed...
Carbonatix Pre-Player Loader

Audio By Carbonatix

How bad is pancreatic cancer? Ninety percent of people who find out they have it die within a year. And the pancreas isn’t even a brand-name digestive organ, like the kidney or liver.

The ghastly statistic is one reason the gene-science gurus at TGen in Phoenix are major recipients in $74 million of gifts being distributed nationwide by the Stand Up to Cancer foundation. TGen’s getting $18 million.

What’s great about this foundation is the aim to put research into practice — and make patients well — ASAP. The research conducted by TGen with its share of the gifts will be tried out at Scottsdale Healthcare at Shea hospital.

TGen says its role will be to:

Editor's Picks

…launch a series of innovative clinical trials in advanced pancreatic cancer. These clinical trials will be designed to deprive pancreatic tumors of crucial nutrients, thereby cutting off the fuel supply.

Sounds like a plan.

GET MORE COVERAGE LIKE THIS

Sign up for the This Week’s Top Stories newsletter to get the latest stories delivered to your inbox

Loading latest posts...